VT News

Antonio Shalfoon

Ask VT AI
View News Summary
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Mystics trade Aaliyah Edwards to Sun for Jacy Sheldon, swap 2026 first-round picks
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Mystics trade Aaliyah Edwards to Sun for Jacy Sheldon, swap 2026 first-round picks
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Antonio Shalfoon

Top Topics

Trending in U.S.

World

Sport